NeuroOne Medical Technologies Corporation (NMTC) NASDAQ

0.63

+0.023(+3.77%)

Updated at May 09 12:13PM

Currency In USD

NeuroOne Medical Technologies Corporation

Address

7599 Anagram Drive

Eden Prairie, MN 55344

United States of America

Phone

952 426 1383

Sector

Healthcare

Industry

Medical - Devices

Employees

17

First IPO Date

March 15, 2018

Key Executives

NameTitlePayYear Born
Mr. David A. Rosa M.D.President, Chief Executive Officer & Director750,1681964
Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison260,8481967
Mr. Steven MertensChief Technology Officer332,2631963
Mr. Christopher R. Volker CFAChief Operating Officer377,111N/A
Mr. Ronald W. McClurgChief Financial Officer386,0561960
Mr. Hijaz HarisVice President of Marketing0N/A

Description

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.